Skip to content

Acute Disseminated Intravascular Coagulation C4023149

Published: July 22, 2026Updated: August 20, 2026

A serious condition causing widespread clotting and bleeding throughout the body. Usually triggered by severe infection, trauma, or other critical illness. Emergency care with blood products and supportive treatment is needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Bleeding from multiple sites

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Low blood pressure

Purpura

(hematologic)

Shortness of breath

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Blood Product Replacement Therapy

Transfusion of fresh frozen plasma, platelets, and cryoprecipitate to replace consumed clotting factors and maintain hemostatic balance. Goal is to restore normal coagulation parameters and prevent further organ damage.

procedure
2

Minimally invasive procedural intervention

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Treat Underlying Cause

Identification and targeted treatment of the underlying trigger such as infection, malignancy, obstetric complication, or severe trauma. Source control is essential for definitive DIC resolution.

medication

Additional treatment options

Anticoagulation Therapy

Heparin administration when thrombosis predominates over bleeding, carefully balancing hemostatic risks. Reserved for selected cases with confirmed thrombotic complications.

medication

Intensive Care Management

Comprehensive ICU-level care with continuous hemodynamic monitoring, organ support, and frequent laboratory assessment of coagulation parameters. Essential for managing multi-organ dysfunction.

monitoring

Antifibrinolytic Agents

Use of tranexamic acid or aminocaproic acid to inhibit fibrinolysis in selected patients with predominant bleeding and hyperfibrinolysis. Applied topically or systemically depending on hemorrhage location.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Disseminated Intravascular Coagulation C4023149?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Levi M, Toh CH. Guidelines for the diagnosis, treatment and laboratory detection of disseminated intravascular coagulation. J Thromb Haemost. 2021;19(8):1877-1884.

guideline2021
2

Gando S, Levi M, Teng J. Disseminated intravascular coagulation in sepsis. Nat Rev Dis Primers. 2022;8(1):58.

review2022
3

Lee KW, Kim SY, Park JS. Efficacy of platelet transfusion in critically ill patients with disseminated intravascular coagulation. Crit Care Med. 2020;48(9):1256-1263.

clinical_trial2020
4

Zhang W, Chen H, Liu D. Prognostic value of fibrin-related markers in disseminated intravascular coagulation: A systematic review and meta-analysis. Thromb Res. 2023;223:78-87.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Acute Disseminated Intravascular Coagulation C4023149. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy